BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22052334)

  • 1. Convection-enhanced delivery catheter placements for high-grade gliomas: complications and pitfalls.
    Shahar T; Ram Z; Kanner AA
    J Neurooncol; 2012 Apr; 107(2):373-8. PubMed ID: 22052334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.
    Kunwar S; Chang SM; Prados MD; Berger MS; Sampson JH; Croteau D; Sherman JW; Grahn AY; Shu VS; Dul JL; Husain SR; Joshi BH; Pedain C; Puri RK
    Neurosurg Focus; 2006 Apr; 20(4):E15. PubMed ID: 16709020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entry points for catheter placement in convection-enhanced delivery--a retrospective anatomic analysis.
    Dörner L; Nabavi A; Mehdorn HM
    Minim Invasive Neurosurg; 2009 Oct; 52(5-6):229-32. PubMed ID: 20077363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging-Based Assessment of Gadolinium-Conjugated Diethylenetriamine Penta-Acetic Acid Test-Infusion in Detecting Dysfunction of Convection-Enhanced Delivery Catheters.
    van Putten EH; Wembacher-Schröder E; Smits M; Dirven CM
    World Neurosurg; 2016 May; 89():272-9. PubMed ID: 26862025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma.
    Barua NU; Hopkins K; Woolley M; O'Sullivan S; Harrison R; Edwards RJ; Bienemann AS; Wyatt MJ; Arshad A; Gill SS
    Drug Deliv; 2016; 23(1):167-73. PubMed ID: 24786643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convection-enhanced delivery for the treatment of brain tumors.
    Debinski W; Tatter SB
    Expert Rev Neurother; 2009 Oct; 9(10):1519-27. PubMed ID: 19831841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
    Saito R; Tominaga T
    Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical tolerance of corticospinal tracts in convection-enhanced delivery to the brainstem.
    Morgenstern PF; Zhou Z; Wembacher-Schröder E; Cina V; Tsiouris AJ; Souweidane MM
    J Neurosurg; 2018 Dec; 131(6):1812-1818. PubMed ID: 30579270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convection-enhanced delivery to achieve widespread distribution of viral vectors: Predicting clinical implementation.
    Debinski W; Tatter SB
    Curr Opin Mol Ther; 2010 Dec; 12(6):647-53. PubMed ID: 21154156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
    Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
    J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convection-Enhanced Delivery.
    Mehta AM; Sonabend AM; Bruce JN
    Neurotherapeutics; 2017 Apr; 14(2):358-371. PubMed ID: 28299724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.
    Lidar Z; Mardor Y; Jonas T; Pfeffer R; Faibel M; Nass D; Hadani M; Ram Z
    J Neurosurg; 2004 Mar; 100(3):472-9. PubMed ID: 15035283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat convection-enhanced delivery for diffuse intrinsic pontine glioma.
    Bander ED; Ramos AD; Wembacher-Schroeder E; Ivasyk I; Thomson R; Morgenstern PF; Souweidane MM
    J Neurosurg Pediatr; 2020 Sep; 26(6):661-666. PubMed ID: 32977309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convection-enhanced delivery in clinical trials.
    Hall WA; Rustamzadeh E; Asher AL
    Neurosurg Focus; 2003 Feb; 14(2):e2. PubMed ID: 15727423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convection-enhanced drug delivery for glioblastoma: a review.
    D'Amico RS; Aghi MK; Vogelbaum MA; Bruce JN
    J Neurooncol; 2021 Feb; 151(3):415-427. PubMed ID: 33611708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies.
    Jahangiri A; Chin AT; Flanigan PM; Chen R; Bankiewicz K; Aghi MK
    J Neurosurg; 2017 Jan; 126(1):191-200. PubMed ID: 27035164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convection-enhanced delivery for the treatment of glioblastoma.
    Vogelbaum MA; Aghi MK
    Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii3-ii8. PubMed ID: 25746090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.
    Sampson JH; Brady ML; Petry NA; Croteau D; Friedman AH; Friedman HS; Wong T; Bigner DD; Pastan I; Puri RK; Pedain C
    Neurosurgery; 2007 Feb; 60(2 Suppl 1):ONS89-98; discussion ONS98-9. PubMed ID: 17297371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
    Pöpperl G; Goldbrunner R; Gildehaus FJ; Kreth FW; Tanner P; Holtmannspötter M; Tonn JC; Tatsch K
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1018-25. PubMed ID: 15877226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.